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Abstract
The chemical constituents and biological activities of the terrestrial Aspergillus flavipes MM2 isolated from Egyptian
rice hulls are reported. Seven bioactive compounds were obtained, of which one sterol: ergosterol (1), four
butyrolactones: butyrolactone I (2), aspulvinone H (3), butyrolactone-V (6) and 4,4’-diydroxypulvinone (7), along
with 6-methylsalicylic acid (4) and the cyclopentenone analogue; terrien (5). Structures of the isolated compounds
were deduced by intensive studies of their 1D & 2D NMR, MS data and comparison with related structures. The
strain extract and the isolated compounds (1-7) were biologically studied against number of microbial strains, and
brine shrimp for cytotoxicity. In this article, the taxonomical characterization of A. flavipes MM2 along with its
upscale fermentation, isolation and structural assignment of the obtained bioactive metabolites, and evaluate their
antimicrobial and cytotoxic activities were described.
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1. Background
In recent years, numerous metabolites possessing
uncommon structures and potent bioactivity have been
isolated from strains of bacteria and fungi collected
from diverse environments, such as soils, animals, plants
and sediments [1,2]. It was noted until Alexander Flem-
ing discovered penicillin G from Penicillium notatum
almost 83 years ago (1928) that fungal microorganisms
suddenly became a hunting ground for novel drug leads
[3,4]. Therefore, many pharmaceutical companies and
research groups were motivated to start sampling and
screening large collections of fungal strains for antibio-
tics [3,5,6]. Antimycotics [7,8], antivirals [9], anticancers
[10] and pharmacologically active agents [11]. The
Aspergilli represents a large diverse genus, containing
ca. 180 filamentous fungal species, of substantial
pharmaceutical and commercial values [12]. In the
research program to explore promising bioactive sec-
ondary metabolites from fungi, the terrestrial fungi,
Aspergillus flavipes sp. isolate MM2 obtained from rice
hulls, was investigated. The strain extract revealed the
presence of promising antimicrobial activity against
some pathogenic test organisms. Chemical screening
(TLC investigation) of the strain extract showed numer-
ous characteristic bands. Therefore, the strain was
applied to large-scale fermentation by using Czapeck-
Dox medium [13]. Working up of the strain cells pro-
duced ergosterol (1), while the filtrate extract afforded
six diverse metabolic compounds: butyrolactone-I (2),
aspulvinone H (3), 6-methylsalicylic acid (4), terrien (5),
butyrolactone-V (6) and 4,4’-diydroxypulvinone (7). The
chemical structures of the isolated compounds (1-7)
were identified with the help of NMR (1D & 2D) and
mass spectrometry (ESI, EI, HRESIMS) (Figure 1). The
antimicrobial activity was tested against some microor-
ganisms and cytotoxicity was examined by using brine
shrimp.
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2. Results and discussion
2.1. Taxonomical characterization of the fungal strain
The grown colonies of the fungal strain on Czapek-Dox
medium showed bright whit-faint yellow colonies on the
agar plate with a brown staining background [13]. The
colonies are growing rather slowly, showing whitish
from conidial masses, with brownish conidiophores
shining through, reverse yellow-brown to red brown
conidial heads spas, loosely columnar, conidiophores
smooth-walled, pale yellow to light brown 2.4-3.2 μm in
diameter. According to its morphological and micro-
scopic characteristics and comparison with the taxono-
mical keys of Raper and Fennel [14], the strain was
assigned as A. flavipes MM2.
2.2. Fermentation, working up and isolation
Based on the pre-screening study, the fungal strain A.
flavipes MM2, cultivated on Czapeks-Dox for 10 days at
28°C, was shown to exhibit biological and chemical
interest results. Therefore, the fungal strain was scaled
up as 10 L culture using the same cultivating conditions
applied for screening studies. After harvesting, both
supernatant and mycelial cake phases were individually
worked up. Purification of the mycelial extract using
silica gel column, followed by washing the afforded
major fraction by methanol and purification with Sepha-
dex LH-20, yielded ergosterol (1). An application of the
culture filtrate extract of A. flavipes MM2 to silica gel
column chromatography, followed by diverse
Figure 1 Structural formula of the investigated compounds (1-10).
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chromatographic techniques, resulted in the isolation of
six compounds: butyrolactone-I (2), aspulvinone H (3),




Ergosterol (1) was obtained as colourless solid, showing
UV activity during TLC, which turned violet on spraying
with anisaldehyde/sulphuric acid and changed latter to
blue. Structure of 1 was confirmed by different spectro-
scopic means (EI MS, 1H, 13C/APT NMR), chromato-
graphic and comparison with literature [15,16].
Ergosterol plays an important role as inhibitor of lipid
per-oxidation and showed strong DPPH radical scaven-
ging activity as well [17,18], along with its cytotoxicity
against HL-60 cells [19], MCF-7 cell line [20].
2.3.2. Butyrolactone-I (2)
The molecular weight of 2 was established as 424 Dal-
ton by ESI MS, having the corresponding molecular for-
mula C24H24O7 and 13 unsaturation bonds.
1H/H,H
COSY NMR spectra of 2 showed two o-doublets (J ~
8.8 Hz) each of 2H at δ 7.57 and 6.86, being for 1,4-dis-
ubstituted aromatic residue, along with three signals at δ
6.50, 6.48 and 6.40 representing 1,3,4-trisubstituted aro-
matic ring. A triplet signal of 1H was at δ 5.05, repre-
senting an olefinic methine linked to a doublet
methylene signal appeared at δ 3.06. A 3H methoxy
group (3.76); doublet of an AB methylene group (δ 3.42)
attached to sp2 system; and further two singlet methyls
were visible at δ 1.65 and 1.56, representing a prenyl
system.
According to the 13C NMR/HMQC spectra of com-
pound 2, 22 carbon signals representing 24 carbons
were displayed, including 2 carbonyls (δ 171.6 and
170.3), 2 sp2 oxygenated carbons (δ 159.3, 155.0) of phe-
nolic systems, along with 5 quaternary carbons (δ 139.6-
123.1). Two 2CH sp2 methine signals (130.4 and 116.6)
for 1,4-disubstituted benzene ring beside to four sp2
methines (δ 132.4-115.0). In the aliphatic region, signals
for quaternary oxygenated methine (δ 86.8), methoxy
(53.8), two methylenes (δ 39.6, 28.7) and two methyls (δ
25.9, 17.8) were assigned. Finally, structure of 2 was
further deduced on the basis of HMBC experimental
data, and comparison with literature as Butyrolactone-I
[21,22]. Butyrolactone-I (2) was reported as a lipid low-
ering agent of Lovastatin × [19,23,24], showing antiproli-
ferative activity against colon, pancreatic carcinoma,
human lung cancer and prostatic cancer [25-30] (Figure
2).
2.3.3. Aspulvinone H (3)
Based on the ESI MS, the molecular weight of 3 was
deduced as 432 Dalton, and the corresponding
molecular formula as C27H28O5, containing 14 unsatura-
tion bonds, as closely related to butyrolactone-I (2). 1H
NMR spectrum of 3 showed six confused doublets each
of 1H between δ 7.81 and 6.73, being of two unsymme-
trical tri-substituted aromatic residues, and singlet
methine at δ 6.22. A multiplet of 2H (δ 5.36), 4H of two
attached sp2-bounded methylenes (δ 3.40-3.00) and mul-
tiplet signal (δ 1.75, 12H) of four sp2-linked methyls,
assigning two prenyl systems. Based on the revealed
NMR data and molecular formula, and search in Anti-
Base [2], structure of 3 was fixed as aspulvinone H [31].
2.3.4. 6-Methylsalicylic acid (4)
According to the ESI mass spectra, the molecular weight
of 4 was deduced as 152 Dalton. The 1H NMR spec-
trum displayed three 1H resonating signals in the aro-
matic region (7.07, 6.63, 6.59), being of 1,2,3-
trisubstiuted aromatic ring (J ~ 7.5-8.2 Hz) together
with a singlet 3H of an aromatic bounded methyl (δ
2.56). Based on the 13C NMR spectrum, compound 4
displayed eight carbon signals, including one quaternary
(δ 176). Two further deep field quaternaries were visible
(δ 162.7 and 142.7) for a-peri-hydroxy and methyl-sp2
attached carbons, respectively. Three sp2 methines (δ
132.2, 122.9, 115.1), one quaternary (δ 119.5) and a
methyl signal (δ 23.3). In accordance, 2-Hydroxy-6-
methyl-benzoic acid (4) was recognized [32,33] as anti-
fungal substance [34], in addition to its analgesic [35],
herbicidal [36] and antiacne activities [37].
2.3.5. Terrein (5)
The molecular weight of 5 was deduced as 154 Dalton
(C8H10O3), bearing four double bond equivalents. The
1H NMR/H,H COSY spectrum of 5 showed two signals
at δ 6.82 and 6.42 (J ~ 15 Hz), representing a trans-ole-
finic double bond, attached to a doublet methyl (δ 1.97),
constructing a terminal propene system. A further sing-
let (δ 5.99) being of an olefinic methine and two doub-
lets each of 1H (δ 4.67, 4.07, J ~ 2.8 Hz) corresponding
to adjacent oxy-methines. According to 13C NMR/
HMQC spectra, eight carbon signals were displayed,
including an acetophenone carbonyl (δ 205.6) and a
deep field sp2 quaternary carbon (δ 170.8); three sp2
methines (δ 141.8, 126.4 and 125.9), two sp3 oxy-
methines (δ 82.4, 78.1) and one sp2-bounded methyl
group (19.5).
A final interpretation of 5 was carried out by HMBC
experiment (Figure 3), fixing the structure as 4,5-dihy-
droxy-3-propenyl-cyclopent-2-enone; terrein [38,39].
Terrein (5) has a hypopigmentary effect in Mel-Ab cells,
and it is a strongly down-regulator of melanin synthesis
by reducing tyrosinase production [40], and inhibit
human platelet aggregation [41]. Terrein showed a
strong antiproliferative effect on skin equivalents [42]
and as proteasome inhibitor and anti-tumoral drug [43].
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2.3.6. Butyrolactone-V (6)
The molecular weight of 6 was established as 440 Dal-
ton (C24H24O8), containing 13 double bond unsatura-
tions. The 1H NMR/H,HCOSY spectrum of compound
6 revealed the presence 1,4-disubstituted (δ 7.54 and
6.85, J ~ 8.8 Hz), and unsymmetrical tri-substituted (m,
δ 6.48) aromatic systems. A 1H dd signal (δ 5.02) of an
oxygenated methine attached to a dd signal (δ 2.80) of a
methylene group, confirming their ABX property. A
singlet of methoxy group (δ 3.77), 2H methylene singlet
(δ 3.40) flanked by two sp2 systems, and two methyl
singlets (δ 1.25 and 1.16), being of gem dimethyl groups
were deduced.
Based on the 13C NMR/HMQC spectra of compound
6, two carbonyls (δ 171.5 and 170.3), two phenolic car-
bons (δ 159.4 and 153.3), b-quaternary carbon (δ 139.6)
of an ester or lactone system were deduced. Two 2CH
sp2 signals (δ 130.4, 116.6), and 3CH sp2 signals (δ
132.9, 130.4, 117.2), being of 1,4-disubstitued and
unsymmetric tri-substituted phenolic residues were
shown. Two sp3 quaternary oxy-carbons (δ 86.8 and
78.0), one oxy-methine (δ 70.4), one carbomethoxy (δ
53.9) and two methylenes (δ 39.0, 2.80) were visible.
Two gem dimethyl signals attached to an oxygenated
quaternary carbon were displayed (δ 25.9, 20.9).
Based on the above spectroscopic data and molecular
formula, compound 6 exhibited a strong close structural
similarity to butyrolactone-I (2). In accordance, three
structural formulas were proposed according to search
in AntiBase: butyrolactone-V (6) [44,45], 4-hydroxy-2-
[2-(1-hydroxy-1-methyl-ethyl)-2,3-dihydro-benzofuran-
5-ylmethyl]-3-(4-hydroxy-phenyl)-5-oxo-2,5-dihydro-
furan-2-carboxylic acid methyl ester (8) [21] and butyro-
lactone-III (9) [19].
The structure was confirmed by detailed 2D experi-
ments; H,H COSY and HMBC (Figure 4) and compari-
son with literature as butyrolactone-V (6) [25,42,43].
Butyrolactone-V was reported to exhibit a moderate
antimalarial activity against the malarial parasite Plasmo-
dium falciparum K1 (IC50 7.9 μg/mL) [45].
2.3.7. 4,4’-Diydroxypulvinone (Aspulvinone E) (7)
Compound 7 was obtained with a molecular weight of
296 Dalton (C17H12O5) by HRESI MS, bearing 12 dou-
ble bond equivalents. The 1H NMR spectrum of 7
showed five signals in the aromatic region for 9H (δ
8.06-5.88), representing two 1,4-disubstitued phenolic
residues (J ~ 8.6 Hz). The fifth signal (1H) was shown
as singlet at δ 5.88. Based on the revealed spectroscopic
data and molecular formula and search in AntiBase, two
alternatives, 4,4’-diydroxypulvinone (7) and Gyrocyanin
(10) were displayed. However, the chemical shift of the
singlet methine in compound 10 has high field shifting
(δ 4.96), which was not matching with our revealed
spectral data, establishing the structure as 4,4’-diydroxy-
pulvinone (7) [46].
Figure 2 H,H COSY (↔) and HMBC (®) correlations of
butyrolactone-I (2).
Figure 3 H, H COSY (▬) and HMBC (®) correlations of Terrein
(5).
Figure 4 Full H,H COSY (↔, ▬) and HMBC (®) correlations of
Butyrolactone-V (6).
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2.4. Biological activities
Activity patterns of the mycelial and supernatant
extracts produced by fungal strain A. flavipes MM2
against set of microorganisms namely, Staphylococcus
aureus, Pseudomonas aeruginosa, Candida albicans and
Aspergillus niger were carried out using agar disc
method (25 μg/disc, ∅ 5 mm). In accordance, both
extracts showed high antibacterial (16-14 mm) and
moderate anti-yeast and antifungal (10-14 mm) activities
(Table 1).
Alternatively, the isolated compounds 1-7 were tested
against Bacillus subtilis, S. aureus, Streptomyces virido-
chromogenes (Tü 57), Escherichia coli, C. albicans,
Mucor miehi, Chlorella vulgaris, Chlorella sorokiniana,
Scenedesmus subspicatus, Rhizoctonia solani and
Pythium ultimum (40 μg/disc, ∅ 9 mm). According to
this study, only four compounds (1, 2, 4, 7) were active.
Ergosterol (1) was highly and moderately active against
S. aureus and B. subtilis. Compounds 7, 4 and 3 showed
high and moderate activity against S. aureus,. Finally,
the whole studied compounds were tested against brine
shrimp (10 μg/mL) for cytotoxic activities, exhibiting no
cytotoxicity except ergosterol (1), which showed 100%
cytotoxicity after 15 h (Table 2).
3. Experimental
NMR spectra were measured on Varian Unity 300 and
Varian Inova 600 spectrometers. Electron spray ioniza-
tion mass spectrometry (ESI HRMS): Finnigan LCQ ion
trap mass spectrometer coupled with a Flux Instruments
(Basel, Switzerland) quaternary pump Rheos 4000 and a
HP 1100 HPLC (nucleosil column EC 125/2, 100-5, C
18) with autosampler (Jasco 851-AS, Jasco Inc., Easton,
MD, USA) and a Diode Array Detector (Finnigan Sur-
veyor LC System). High-resolution mass spectra
(HRMS) were recorded by ESI MS on an Apex IV 7
Tesla Fourier-Transform Ion Cyclotron Resonance Mass
Spectrometer (Bruker Daltonics, Billerica, MA, USA). EI
MS at 70 eV with Varian MAT 731, Varian 311A,
AMD-402, high-resolution with perflurokerosine as
standard. Rf values were measured on Polygram SIL F/
UV254 (Merck, pre-coated sheets). Size exclusion chro-
matography was done on Sephadex LH-20 (Pharmacia).
3.1. Isolation and taxonomy of the producing strain
The terrestrial A. flavipes MM2, which was identified
according to the Raper and Fennel [14], has been
isolated from rice hulls sample by placing the rice hulls
over water agar medium (g/L): Agar-agar (20) and water
(100%) with incubation at 28°C for 7 days the develop-
ing colony was transferred to Czapeks agar with incuba-
tion at 28°C for 10 days. Bright whit-faint yellow
colonies with a brown straining background of the fun-
gal strain were grown. The colonies are growing rather
slowly, showing whitish from conidial masses, with
brownish conidiophores shining through, reverse yellow-
brown to red brown Conidial heads spas, loosely colum-
nar, conidiophores smooth-walled, pale yellow to light
brown 2.4-3.2 μm diameter. According to its morpholo-
gical and microscopic characteristics and comparison
with literature, the fungal strain was assigned as A. fla-
vipes MM2 [14]. The strain is deposited in Dr Moham-
mad Magdy El Metwally collection in Microbiology
Department, Soil & Water and Environment Research
Institute, ARC, Giza, Egypt.
3.2. Fermentation, extraction and isolation
Small pieces (1 cm2) of well grown sub-cultures of A.
flavipes MM2 were inoculated into thirty 1-L Erlen-
meyer flasks, each containing 300 mL of sterilized Cza-
peck-Dox medium (g/L): Sucrose (30), NaNO3 (3),
K2HPO4 (1), KCl (0.5), MgSO4 (0.5), FeSO4 (0.01) and
distilled water (1 L) at pH = (7.3). The inoculated flasks
were incubated for 10 days at 28°C and 100 rpm. After
harvesting, the fungal mate and supernatant were sepa-
rated by filtration. The fungal mat was then applied to
maceration in methanol (3 × 0.5 L). The methanol
extract was concentrated in vacuum and the remaining
aqueous solution was re-extracted by ethyl acetate fol-
lowed by concentration to yield 845 mg as brown crude
extract. The supernatant was passed through XAD-16
column (4 × 120 cm). After washing with water, the
absorbed organic extract was eluted by methanol, fol-
lowed by concentration under vacuum, and the aqueous
residue was re-extracted by ethyl acetate, followed by
concentration in vacuo to afford 818 mg as brown
crude extract.
The mycelial extract (845 mg) was subjected to frac-
tionation using silica gel column chromatography
(cyclohexane-CH2Cl2-MeOH) to afford 200 mg as major
fraction, which was then washed by MeOH to deliver a
colourless precipitate. The last precipitate was purified
on Sephadex LH-20 (CH2Cl2/40% MeOH) to afford
Ergosterol (1, 12 mg) as colourless solid.
Table 1 Pre-antimicrobial assays of A. flavipes MM2 (j mm)
Medium no. Inhibition zone (mm)
Culture filtrate extract Cells extract
St.
aureus
Ps. aeruginosa, C. albicans A. niger St. Aureus Ps. aeruginosa, C. albicans A. niger
Czapeck-Dox 15 16 14 12 14 14 10 10
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The filtrate crude extract (818 mg) was fractionated
on silica gel column and eluted by cyclohexane-CH2Cl2-
MeOH gradient to give five fractions (I-V). Fraction FIII
was further fractionated using Sephadex LH-20 column
(MeOH) to afford two sub-fractions, FIIIa (44 mg) and
FIIIb (73 mg). Purification of FIIIa by Sephadex LH-20
(MeOH) afforded a colourless solid of butyrolactone-I
(2, 4 mg). PTLC purification (CH2Cl2/5%MeOH) of
FIIIb followed by Sephadex LH-20 (MeOH) afforded
Aspulvinone H (3) as colourless solid (3 mg). A further
fractionation of FIV on Sephadex LH-20 (MeOH) led to
sub-fractions FIVa (35 mg) and FIVb (120 mg). Purifica-
tion of sub-fraction FIVa using Sephadex LH-20
(MeOH), PTLC (CH2Cl2/5% MeOH), and then Sepha-
dex LH-20 (MeOH) resulted in 6-methylsalicylic acid (4,
10 mg) as colourless solid. Sub-fraction FIVb was puri-
fied on Sephadex LH-20 (MeOH) to afford Terrien (5,
10 mg) and butyrolactone-V (6, 2 mg) as two colourless
solids. Finally, fraction FV was purified using two subse-
quent Sephadex LH-20 columns (MeOH) to give a yel-
low solid of 4,4’-diydroxypulvinone (7, 4 mg).
3.2.1. Ergosterol; ergosta-5,7,22-triene-3b-ol (1)
C28H44O (396), colourless solid, UV-absorbing, turned
violet with anisaldehyde/sulphuric acid, Rf = 0.46
(CH2Cl2/5%MeOH);
1H NMR (CDCl3, 300 MHz): δ =
5.57 (dm, 1H, H-6), 5.38 (dm, 1H, H-7), 5.17 (m, 2H,
H-22,23), 3.62 (m, 1H, H-3), 2.46 (dm, 1H, H-5), 2.35
(m, 2H, H-20, 24), 2.09-1.93 (m, 3H), 1.92-1.89 (m, 4H),
1.88-1.55 (m, 4H), 1.50-1.40 (m, 3H), 1.38-1.16 (m, 3H),
1.02 (d, J = 7.2, 3H, CH3-21), 0.93 (s, 3H, CH3-19), 0.91
(d, J = 7.2, 3H, CH3-28), 0.82 (d, J = 6.8, 3H, CH3-27),
0.80 (d, J = 6.8, 3H, CH3-26), 0.61 (s, 3H, CH3-18);
13C
NMR (CDCl3, 75 MHz): δ = 141.3 (Cq-8), 139.8 (Cq-5),
135.5 (CH-22), 131.9 (CH-23), 119.6 (CH-7), 116.3 (CH-
6), 70.4 (CH-3), 55.7 (CH-17), 54.5 (CH-14), 46.2 (CH-
9), 42.8 (Cq-13), 42.8 (CH-24), 40.7 (CH2-4), 40.4 (CH-
20), 39.1 (CH2-12), 38.4 (CH2-1), 37.0 (Cq-10), 33.1
(CH-25), 32.0 (CH2-2), 28.3 (CH2-16), 23.0 (CH2-11),
21.1 (CH2-15), 21.1 (CH3-21), 19.9 (CH3-27), 19.6 (CH3-
26), 17.6 (CH3-28), 16.2 (CH3-19), 12.0 (CH3-18); EI-
MS (70 EV): m/z (%) = 396 ([M]+, 87), 378 ([M-H2O]
+,
12), 363 ([M-(H2O+CH3)]
+, 100), 271 (25), 253 (52), 211
(33).
3.2.2. Butyrolactone-I (2)
C24H24O7 (424), colourless solid, UV-absorbing, turned
violet with anisaldehyde/sulphuric acid, Rf = 0.39
(CH2Cl2/5% MeOH);
1H NMR (CD3OD, 300 MHz): δ =
7.57 (d, J = 8.8 Hz, 2H, H-2’,6’), 6,86 (d, J = 8.8 Hz, 2H,
H-3’,5’), 6.50 (dd, J = 7.1, 2.0 Hz, 1H, H-6”), 6.48 (d, J =
8.1 Hz, 1H, H-5”), 6.40 (d, J = 1.7, 1H, H-2”), 5.05 (t, J
= 3.7 Hz, 1H, H-8”), 3.76 (s, 3H, 7-OCH3), 3.42 (d, J =
3.9, 2H, CH2-5), 3.06 (d, J = 7.3 Hz, 2H, CH2-7”), 1.65
(s, 3H, CH3-10”), 1.56 (s, 3H, CH3-11”);
13C NMR
(CD3OD, 75 MHz): δ = 171.6 (Cq-6), 170.3 (Cq-1), 159.3
(Cq-4’), 155.0 (Cq-4”), 139.6 (Cq-3), 133.0 (Cq-9”), 132.4
(CH-2”), 130.4 (CH-2’,6’), 129.8 (CH-6”), 129.2 (Cq-3”),
125.0 (Cq-1”), 123.1 (Cq-1’), 123.6 (CH-8”), 116.6 (CH-
3’,5’), 115.0 (CH-5”), 86.8 (Cq-4), 53.8 (OCH3-7), 39.6
(CH2-5), 28.7 (CH2-7”), 25.9 (CH3-10”), 17.8 (CH3-11”);
-(+)ESI MS: m/z (%) = 447 ([M+Na]+, 81), 871 ([2M
+Na]+, 100); -(-)ESI MS: m/z (%) = 423 ([M-H]-, 13),
847 ([2M-H]-, 4); (+)-HRESI: m/z = 447.1414 [M+Na]+
(calc. 447.1414 for C24H24NaO7); (-)-HRESI: m/z
423.1435 [M-H]- (calc. 423.1449 for C24H23O7).
3.2.3. Aspulvinone H (3)
C27H28O5 (432), colourless solid, UV-blue fluorescent,
turned yellow with anisaldehyde/sulphuric acid, Rf =
0.62 (CH2Cl2/10% MeOH),
1H NMR (CD3OD, 300
MHz): δ = 7.81 (d, J = 1.8 Hz, 1H, H-2’), 7.68 (m, 1H,
H-6’), 7.59 (m, 1H, H-6”), 7.44 (d, J = 1.6 Hz, H-2”),
6.73 (m, 2H, H-5’,5”), 6.22 (s, H-5), 5.36 (m, 2H, H-
8’,8”), 3.40-3.00 (m, 4H, H2a, b-7’, H2a, b-7”), 1.75 (m,
12H, H3-10’,11’,10”,11”); -(+)ESI MS: m/z (%) = 455 ([M
+Na]+, 56), 477 ([M+2Na-H]+, 100), 887 ([2M+Na]+, 5);
-(-)ESI MS: m/z (%) = 431 ([M-H]-, 100), 863 ([2M-H]-,
4), (+)-HRESI: m/z 455.1808 [M+Na]+ (calc. 455.1829
for C27H28NaO5); (-)-HRESI: m/z 431.1860 [M-H]
-
(calc. 431.1864 for C27H27O5).
3.2.4. 6-Methylsalicylic acid (4)
C8H8O3 (152), colourless solid, UV-absorbing, Rf = 0.24
(CH2Cl2/5%MeOH);
1H NMR (CD3OD, 300 MHz): δ =
7.07 (t, J = 7.7 Hz, 1H, 4-H), 6.63 (d, J = 8.2 Hz, 1H, 3-
Table 2 Antimicrobial assays of A. flavipes MM2 compounds (j mm)




















Ergosterol (1) 11 19 ND ND ND ND ND ND ND ND ND 100%
Butyrolactone I (2) ND ND ND ND ND ND ND ND ND ND ND ND
Aspulvinone H (3) ND 11 ND ND ND ND ND ND ND ND ND ND
6-methylsalicylic acid (4) ND 15 ND ND ND ND ND ND ND ND ND ND
Terrien (5) ND ND ND ND ND ND ND ND ND ND ND ND
Butyrolactone-V (6) ND ND ND ND ND ND ND ND ND ND ND ND
4,4’-diydroxypulvinone (7) ND 18 ND ND ND ND ND ND ND ND ND ND
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H), 6.59 (d, J = 7.5 Hz, 1H, 5-H), 2.56 (s, 3H, CH3-7);
13C NMR (CD3OD, 75 MHz): δ = 176 (Cq-8), 162.7
(Cq-2), 142.7 (Cq-6), 132.1 (CH-4), 122.9 (CH-3), 119.5
(Cq-1), 115.1 (CH-5), 23.3 (CH3-7); -(+)ESI MS: m/z (%)
= 175 ([M+Na]+, 25), 371 ([2M+3Na-2H]+, 55); -(-)ESI
MS: m/z (%) = 151 ([M-H]-, 100), 303 ([2M-H]-, 4).
3.2.5. Terrine (5)
C8H10O3 (154), colourless solid, UV-absorbing, turned
dark green on spraying with anisaldehyde/sulphuric
acid, Rf = 0.51 (CH2Cl2/10%MeOH);
1H NMR (CD3OD,
300 MHz): δ = 6.82 (ddd, J = 13.7, 8.9, 6.8 Hz, 1H, H-
2), 6.42 (dd, J = 15.8, 1.1 Hz, 1H, H-3), 5.99 (s, 1H, H-
5), 4.67 (d, J = 2.4 Hz, 1H, H-8), 4.07 (d, J = 2.7 Hz, 1H,
H-7), 1.97 (dd, J = 6.8, 1.4 Hz, 3H, 1-CH3);
13C NMR
(CD3OD, 75 MHz): δ = 205.6 (Cq-6), 170.8 (Cq-4), 141.8
(CH-2), 126.4 (CH-3), 125.9 (CH-5), 82.4 (CH-7), 78.1
(CH-8), 19.5 (CH3-1); -(+)ESI MS: m/z (%) = 177 ([M
+Na]+, 62), 331 ([2M+Na]+, 100); -(-)ESI MS: m/z (%) =
153 ([M-H]-, 34), 307 ([2M-H]-, 4); (+)-HRESI MS: m/z
177.0528 [M+Na]+ (calc. 177.0522 for C8H10NaO3);
(-)-HRESI MS: m/z 153.0553 [M-H]- (calc. 153.0557 for
C8H9O3).
3.2.6. Butyrolactone-V (6)
C24H24O8 (440), colourless solid, UV-absorbing, turned
pink with anisaldehyde/sulphuric acid, Rf = 0.12
(CH2Cl2/5% MeOH),
1H NMR (CD3OD, 300 MHz): δ =
7.54 (d, J = 8.8 Hz, 2H, H-2’,6’), 6.85 (d, J = 8.8 Hz, 2H,
H-3’,5’), 6.48 (m, 3H, H-2”,5”,6”), 5.02 (dd, J = 5.2, 2.0
Hz, 1H, H-8”), 3.77 (s, 3H, OCH3-7), 3.40 (s, 2H, CH2-
5), 2.80 (dd, J = 5.2, 16.9 Hz, 2H, CH2-7”), 1.25 (s, 3H,
CH3-10”), 1.16 (s, 3H, CH3-11”);
13C NMR (CD3OD, 75
MHz): δ = 171.5 (Cq-6), 170.3 (Cq-1), 159.4 (Cq-4’),
153.3 (Cq-4”), 139.6 (Cq-3), 132.9 (CH-2”), 130.4 (CH-
2’,6’), 130.4 (CH-6”), 120.5 (Cq-3”), 126.0 (Cq-1”), 123.1
(Cq-1’), 116.6 (CH-3’,5’), 117.2 (CH-5”), 86.8 (Cq-4), 78.0
(Cq-9”), 70.4 (CH-8”), 53.9 (OCH3-7), 39.5 (CH2-5), 32.0
(CH2-7”), 25.8 (CH3-10”), 20.9 (CH3-11”); -(+)ESI MS:
m/z (%) = 441 ([M+H]+, 30), 463 ([M+Na]+, 57.5), 881
([2M+H]+, 25), 903 ([2M+Na]+, 50); -(-)ESI MS: m/z
(%) 439 ([M-H]-, 3); (+)-HRESI: m/z 463.1370 [M+Na]+
(calc. 463.1363 for C24H24NaO8); (-)-HRESI: m/z
439.1399 [M-H]- (calc. 439.1389 for C24H23O8).
3.2.7. 4,4’-Diydroxypulvinone (7)
C17H12O5 (296), colourless solid, UV yellow fluores-
cence, Rf = 0.15 (CH2Cl2/5% MeOH);
1H NMR
(DMSO-d6, 300 MHz): δ = 9.42 (brs, 1H, 4’-OH), 8.70
(brs, 1H, 4"-OH), 8.06 (d, J = 8.6 Hz, 2H, H-2’,6’), 7.51
(d, J = 8.7 Hz, 2H, H-2”,6”), 6.75 (d, J = 8.7 Hz, 2H, H-
3’, 5’), 6.16 (d, J = 8.7 Hz, 2H, H-3”, 5”), 5.88 (s, 1H, H-
5); 13C NMR (DMSO-d6, 300 MHz): δ = 156.1 (Cq-
4’,4”), 152.4 (Cq-4), 130.4 (CH-2’,2”,6’,6”), 126.1 (Cq-1’,
1”), 124.6 (CH-5), 115.3 (CH-3’,5’), 114.1 (CH-3”,5”);
-(+)-ESI MS: m/z (%) = 319 ([M+Na]+, 20), 314 ([M
+2Na-H]+, 30); -(-)ESI MS: m/z (%) = 295 ([M-H]-,
100); (+)-HRESI MS: m/z 319.0587 [M+Na]+ (calc.
319.0577 for C17H12NaO5). (-)-HRESI: m/z 295.0616
[M-H]- (calc. 295.0612 for C17H11O5).
3.3. Biological activities
3.3.1. Antimicrobial activity
Antimicrobial assays were conducted utilizing the disc-
agar method [47]. This has been carried out gainst
diverse sets of microorganisms. A. flavipes MM2 extract
was dissolved in CH2Cl2/10% MeOH at a concentration
of 1 mg/mL. Aliquots of 40 μL were soaked on filter
paper discs (9 mm ∅, no. 2668, Schleicher & Schüll,
Germany) and dried for 1 h at room temperature under
sterilized conditions. The paper discs were placed on
inoculated agar plats and incubated for 24 h at 38°C for
bacterial and 48 h (30°C) for the fungal isolates, while
the algal test strains were incubated at approximately
22°C in day light for 8-10 days. The pure compounds
were examined against the test microorganisms: B. sub-
tilis, S. aureus, S. viridochromogenes (Tü 57), E. coli, C.
albicans, M. miehi, C. vulgaris, C. sorokiniana, S. subspi-
catus, R. solani and P. ultimum.
3.3.2. Brine shrimp microwell cytotoxicity assay
The cytotoxic assay was performed according to Sajid et
al.’s screening [48].
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